Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$474 Buy
11
+3
+38% +$152 ﹤0.01% 1284
2026
Q2
$492 Buy
+8
New +$489 ﹤0.01% 1239
2025
Q4
– Sell
-5
Closed -$432 – 1335
2025
Q3
$432 Sell
5
-20
-80% -$1.51K ﹤0.01% 1259
2025
Q2
$1.71K Sell
25
-28
-53% -$1.73K ﹤0.01% 1134
2025
Q1
$3.15K Buy
+53
New +$3.36K ﹤0.01% 1080
2023
Q4
– Sell
-13
Closed -$1.28K – 596
2023
Q3
$1.28K Buy
+13
New +$1.34K ﹤0.01% 587
2022
Q1
– Sell
-55
Closed -$9K – 704
2021
Q4
$9K Hold
55
– – ﹤0.01% 568
2021
Q3
$8K Buy
+55
New +$8.56K ﹤0.01% 498

Other funds holding APTV

SouthState's APTV Position: Q3 2026 in Review

SouthState increased its Aptiv (APTV) stake by 38% in Q3 2026, buying an estimated $152 and bringing the position to 11 shares worth $474. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

SouthState first reported a position in APTV in Q3 2021 and has held it in 8 quarters since. The position peaked at $9K in Q4 2021. 511 funds tracked by Wall St. Rank hold APTV as of Q3 2026.

  • SouthState held 11 shares of Aptiv worth $474 as of Q3 2026.
  • SouthState bought 3 Aptiv shares in Q3 2026, an estimated $152.
  • Aptiv made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1284 holding.
  • SouthState first reported a position in Aptiv in Q3 2021 and has held it in 8 quarters since.
  • SouthState's Aptiv position peaked at $9K in Q4 2021.
  • 511 funds tracked by Wall St. Rank held Aptiv as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.